Taken together, L971 might contribute to regulation of metabolic disorders through direct influence of PPARγ signalling pathway (Figure 4D) or indirect interfering with JAK/STAT and NFκB signalling pathways. This evidence concerns the gene NFKB1 and metabolic disease.